ARCHIVES

Amgen Agrees To Buy Immunex For $16 Billion In Stock And Cash.

This article is from The Cancer Letter archive.

Vol. 28 No. 04 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

Drugs and Targets: EU approves Imbruvica in MCL, CLL

October 24, 2014

SWOG Closes Prostate Cancer Trial With Mitoxantrone

February 23, 2007

New System Devised To Help Identify Emerging Comprehensive Centers

October 10, 1975

National Dialogue plans biospecimen network

July 18, 2003

The First BRCA1 Test Hits The Market; Are Oncologists, Patients Ready?

January 26, 1996

On Capitol Hill: Cancer Organizations Push Congress For Payment Of Patient Care Costs In Trials

September 17, 1999